Records containing: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-02-29An Observational Cohort Study to Determine Late Outcomes and Immunological Responses After Infection With SARS-CoV-2 in Children With and Without Multisystem Inflammatory Syndrome (MIS-C)
-
CLINICAL_TRIALS study record update · 2023-12-20Phase 2/3 Randomized, Blinded, Placebo-Controlled Trial to Evaluate the Safety, Immunogenicity, and Efficacy of INO-4800, a Prophylactic Vaccine Against COVID-19 Disease, Administered Intradermally Followed by Electroporation in Adults at High Risk of SARS-CoV-2 Exposure
-
CLINICAL_TRIALS study record update · 2023-08-02An Observer-Blinded Phase 3 Study to Evaluate the Safety and Immunogenicity of a Single Booster of the NVX-CoV2373 Vaccine in Adults Previously Vaccinated With the BBIBP-CorV Vaccine
-
CLINICAL_TRIALS study record update · 2023-06-15Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Effect of Anti-CD14 Treatment in Hospitalized Patients With COVID-19
-
CLINICAL_TRIALS study record update · 2023-03-01AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 2, DOUBLE-BLIND, 2-ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED NIRMATRELVIR/RITONAVIR COMPARED WITH PLACEBO/RITONAVIR FOR THE TREATMENT OF SEVERE COVID-19 IN HOSPITALIZED PARTICIPANTS WHO ARE IMMUNOCOMPROMISED OR AT INCREASED RISK FOR SEVERE COVID-19 OUTCOMES
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-02-14Personalized Dietary Advice 3 Months After Discharge From Hospitalization in Geriatrics: Effect on Nutritional Status According to Coronavirus Disease 2019 (Covid-19) Status (Positive or Negative) During Hospitalization
-
CLINICAL_TRIALS study record update · 2023-02-09Comparison of Non-invasive Oxygenation Strategies in ICU Patients Admitted for Covid-19 Acute Respiratory Distress Syndrome
-
CLINICAL_TRIALS study record update · 2023-01-04The Effectiveness of Phytotherapy in the Treatment of SARS-COV2 (COVID-19)
-
CLINICAL_TRIALS study record update · 2022-11-09A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Favipiravir-HU Compared to Placebo as add-on Therapy to Standard of Care in Asymptomatic to Mild Severity COVID-19 Patients
-
CLINICAL_TRIALS study record update · 2022-08-30A Phase 2/3 Study to Evaluate the Safety and Efficacy of Dociparstat Sodium for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure
-
CLINICAL_TRIALS study record update · 2021-04-28Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection
-
CLINICAL_TRIALS study record update · 2021-02-24Intersectoral Platform (SÜP) of the National Pandemic Cohort Network (NAPKON)
-
CLINICAL_TRIALS study record update · 2020-09-17Convalescent Plasma in the Treatment of COVID 19